Rigin

• CAT Number: I035577
• CAS Number: 77727-17-4
• Molecular Formula: C18H32N8O6
• Molecular Weight: 456.50
• Purity: 98%
• Synonyms: Gly-gln-pro-arg; GQPR; Rigin; Tetrapeptide-3; Tetrapeptide-7
• Target: Disease Research Fields
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[(2-aminoacetyl)amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid
• InChI: InChI=1S/C18H32N8O6/c19-9-14(28)24-10(5-6-13(20)27)16(30)26-8-2-4-12(26)15(29)25-11(17(31)32)3-1-7-23-18(21)22/h10-12H,1-9,19H2,(H2,20,27)(H,24,28)(H,25,29)(H,31,32)(H4,21,22,23)/t10-,11-,12-/m0/s1
• InChIKey: UEJYSALTSUZXFV-SRVKXCTJSA-N
• SMILES: C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O

Rigin（Cat No.:I035577）is an investigational compound being studied for its potential in treating neurological and psychiatric conditions, particularly those related to cognitive decline and mood disorders. It is thought to function by modulating neurotransmitter systems, including serotonin and dopamine pathways, to restore balance in the brain. Preclinical studies suggest that Rigin may help improve cognitive function, reduce depressive symptoms, and protect against neurodegenerative processes. Although early results are promising, further clinical trials are required to assess its efficacy, safety, and potential use in treating conditions like Alzheimer’s disease and depression.